Thiogenesis Therapeutics, Corp. (TTI)

Name: Thiogenesis Therapeutics, Corp. (TTI) — Strikepoint signal profile
Creator: Strikepoint News
License: https://creativecommons.org/licenses/by/4.0/
Keywords: TTI, Thiogenesis Therapeutics, Corp., diversified, mining

Thiogenesis Therapeutics, Corp. is a diversified issuer with 1 recent financing.

Ticker: TTI
Exchange: TSXV
Primary commodity: diversified
Sector: mining
Shares outstanding: 51,835,956

Recent financings

other · $100,000,000 (source)

Private placements directory →

Recent news

TETRA Technologies, Inc. Announces Pricing of Public Offering of Common Stockquotemedia_pr_newswire · 2026-06-03
TETRA TECHNOLOGIES, INC. ANNOUNCES PUBLIC OFFERING OF COMMON STOCKquotemedia_pr_newswire · 2026-06-02
TETRA TECHNOLOGIES, INC. BOARD OF DIRECTORS APPROVES FINAL INVESTMENT DECISION FOR ARKANSAS BROMINE PRODUCTION FACILITYquotemedia_pr_newswire · 2026-05-28

All news →

Profile assembled from Strikepoint Newssignal data — drill results, warrant filings, financings, insider transactions, and news. Drill rock value per tonne is the gross in-situ value at today's spot prices, recomputed live. Informational only; verify against original filings before drawing conclusions.